ACE2 expression and spike S1 protein‐mediated immune responses in oral mucosal cells
Oral Diseases · 2024
DOI: 10.1111/odi.14670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Misaki Akagi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Spike Glycoprotein, Coronavirus, Chemokine CXCL10, Mouth Mucosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Grant-in-Aid for Scientific Research from the Japan Society for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology….
Abstract (Originalsprache)
Objectives
ACE2, known as a host receptor involved with SARS‐CoV‐2 infection, binds to viral spike proteins for host cell entry. However, details regarding its induction and function in oral mucosal cells remain unknown. Materials and Methods We examined ACE2 expression and its induction by transfected mimic nucleotides and pro‐inflammatory cytokines in oral keratinocytes (RT7) and fibroblasts (GT1). Subsequently, the effects of viral spike S1 protein via ACE2 on CXCL10 expression induced by pro‐inflammatory cytokines in both cells were examined.
Results
ACE2 was constitutively expressed in RT7 and GT1. Transfected Poly(I:C) and Poly(dA:dT) increased ACE2 expression in those cells, while knockdown of RIG‐I decreased ACE2 expression induced by those transfected ds nucleotides. IFN‐γ and TNF‐α enhanced transfected ds nucleotides‐induced ACE2 expression in RT7 but not GT1. S1 protein alone did not affect CXCL10 expression in either cell type, whereas it enhanced IFN‐β‐induced CXCL10 in both, while immune responses of IFN‐γ‐ and TNF‐α‐induced CXCL10 enhanced by S1 protein were different between RT7 and GT1. Finally, knockdown of ACE2 decreased cytokines and S1 protein mediated‐CXCL10 levels in both cells.
Conclusions
ACE2 in oral mucosal cells may contribute to development of infection and inflammation in cooperation with pro‐inflammatory cytokines following SARS‐CoV‐2 invasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of General Dentistry, Hiroshima University Hospital, Hiroshima, Japan.
ORCID-Profile: Misaki Akagi, Kouji Ohta
Förderung
- Grant-in-Aid for Scientific Research from the Japan Society for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology…
Zitieren
APA
Akagi, M., Ohta, K., Fukada, S., Sakuma, M., Naruse, T., Nakagawa, T., Ono, S., Nishi, H., Shigeishi, H., & Aikawa, T. (2024). ACE2 expression and spike S1 protein‐mediated immune responses in oral mucosal cells. Oral Diseases. https://doi.org/10.1111/odi.14670
Vancouver
Akagi M, Ohta K, Fukada S, Sakuma M, Naruse T, Nakagawa T, et al. ACE2 expression and spike S1 protein‐mediated immune responses in oral mucosal cells. Oral Diseases. 2024. doi:10.1111/odi.14670
BibTeX
@article{Akagi2024,
author = {Akagi, Misaki and Ohta, Kouji and Fukada, Shohei and Sakuma, Miyuki and Naruse, Takako and Nakagawa, Takayuki and Ono, Shigehiro and Nishi, Hiromi and Shigeishi, Hideo and Aikawa, Tomonao},
title = {ACE2 expression and spike S1 protein‐mediated immune responses in oral mucosal cells},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14670}
}
EUVIMED